Inspire Medical Systems9700 63rd Avenue Northsuite 200maple Grove Mn 55369 Pma Numberp130008 Supplement Numbers093 Date Received11 18 2022 Decision Date12 16 2022 Product Code Mnq Advisory Committee Anesthesiology Clinical Trialsnct04457154 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Inspire Medical Systems9700 63rd Avenue Northsuite 200maple Grove Mn 55369 Pma Numberp130008 Supplement Numbers093 Date Received11 18 2022 Decision Date12 16 2022 Product Code Mnq Advisory Committee Anesthesiology Clinical Trialsnct04457154 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P130008S093 INSPIRE MEDICAL SYSTEMS9700 63rd Avenue Northsuite 200maple Grove, MN 55369 PMA NumberP130008 Supplement NumberS093 Date Received11/18/2022 Decision Date12/16/2022 Product Code MNQ  Advisory Committee Anesthesiology Clinical TrialsNCT04457154 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	Inspire II Upper Airway Stimulator	2022-12-16